跳至主要内容
临床试验/EUCTR2008-007492-24-NL
EUCTR2008-007492-24-NL进行中(未招募)不适用

An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasis - PIECE

Academic Medical Center0 个研究点目标入组 120 人开始时间: 2009年1月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Adults patients (18-75 years of age)
  • - Psoriasis Area and Severity Index (PASI > 10) and/or Body Surface Area (BSA) > 10.
  • - Failed, contraindicated and/or intolerant to UV therapy, methotrexate or cyclosporin.
  • - Informed consent
  • - Able to complete Dutch questionnaires.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Pregnancy and lactation
  • - Active (or chronic) infections including Hepatitis B and C viral infections, HIV and tuberculosis
  • - Malignancy in last 10 years, except BCC and cervical in situ cancer
  • - Demyelinating disease
  • - Congestive heart failure (NYHA grade III or IV)
  • - Allergic and hypersensitivity reactions to study drugs or ingredients
  • - Any live virus or bacterial vaccination within 3 months
  • - Severe liverfunction disorders >2 times and/or kidneyfunction disorders >1,5 times upper limits of the parameters.

研究者

发起方
Academic Medical Center

相似试验